Association of the outer membrane protein omp33with fitness and virulence of acinetobacter baumannii

Journal of Infectious Diseases

Volumn 208, Issue 10, 2013, Pages 1561-1570

  Smani, Younes ^a   Dominguez Herrera, Juan ^a   Pachón, Jerónimo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Acinetobacter baumannii; Fitness; Omp33; Virulence

Indexed keywords

AMPICILLIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN 33; TETRACYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BIOFILM; CELL INVASION; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; FEMALE; GENE INACTIVATION; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LETHAL DOSE; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; MACROPHAGE; METABOLIC CAPACITY; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; SPLEEN; WILD TYPE;

ACINETOBACTER BAUMANNII; FITNESS; OMP33; VIRULENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; BACTERIAL ADHESION; BACTERIAL OUTER MEMBRANE PROTEINS; BIOFILMS; CELL DEATH; CELL LINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE KNOCKOUT TECHNIQUES; GENETIC FITNESS; HUMANS; MICE; PERITONITIS; PHENOTYPE; VIRULENCE;

EID: 84888622827     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit386     Document Type: Article

References (25)

1. Spencer RC. Predominant pathogens found in the European Prevalence of Infection in Intensive Care study. Eur J Clin Microbiol Infect Dis 1996; 15:281-5.
2. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323-9.
3. Cisneros JM, Garnacho-Montero J, Pachón-Ibáñez ME. Nosocomial pneumonia due to Acinetobacter baumannii. Enferm Infecc Microbiol Clin 2005; 23:46-51.
4. Smani Y, McConnell MJ, Pachón J. Role of fibronectin in the adhesion of Acinetobacter baumannii to host cells. PLoS One 2012; 7: e33073.
5. Choi CH, Lee EY, Lee Y, et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epitelial cells. Cell Microbiol 2005; 7:1127-38.
6. Antunes LC, Imperi F, Crattoli A, Visca P. Deciphering the multifactorial nature of Acinetobacter baumannii. PLoS One 2011; 6: e22674.
7. Smani Y, Docobo-Pérez F, López-Rojas R, Dominguez-Herrera J, Ibáñez-Martínez J, Pachón J. Platelet-activating factor receptor initiates Acinetobacter baumannii expressing phorphorylcholine contact with host cells. J Biol Chem 2012; 287:26901-10.
8. Smith MG, Gianoulis TA, Pukatzki S, et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 2007; 21:601-14.
9. Aranda J, Poza M, Pardo BG, et al. A rapid and simple method for constructing stable mutants of Acinetobacter baumannii. BMC 2010; 10:279.
10. Roca I, Espinal P, Martí S, Vila J. First identification and characterization of an AdeABC-like efflux pump in Acinetobacter genomospecies 13TU. Antimicrob Agents Chemother 2011; 55:1285-6.
11. Hunger M, Schmucker R, Kishan V, Hillen W. Analysis and nucleotide sequence of an origin of DNA replication in Acinetobacter calcoaceticus and its use for Escherichia coli shuttle plasmids. Gene 1990; 87:45-51.
12. Smani Y, López-Rojas R, Domínguez-Herrera J, Docobo-Pérez F, Martí SVila J. In vitro and in vivo reduced fitness and virulence in ciprofloxacin- resistant Acinetobacter baumannii. Clin Microbiol Infect 2012; 18: E1-4.
13. Smani Y, Dominguez-Herrera J, Pachón J. Rifampin protects human lung epithelial cells against cytotoxicity induced by clinical multi and pandrug-resistant Acinetobacter baumannii. J Infect Dis 2011; 203:1110-9.
14. Tsai YK, Fung CP, Lin JC, et al. Klebsiella pneumoniae outer membrane porins OmpK35 and Omp36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 2011; 55: 1485-93.
15. Cabral MP, Soares NC, Aranda J, et al. Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism. J Proteome Res 2011; 10: 3399-417.
16. Hood MI, Jacobs AC, Sayood K, Dunman PM, Skaar EP. Acinetobacter baumannii increases tolerance to antibiotics in response monovalent cations. Antimicrob Agents Chemother 2010; 54:1029-41.
17. McConnell MJ, Rumbo C, Bou G, Pachón J. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 2011; 29:5705-10.
18. Jin JS, Kwon SO, Moon DC, et al. Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS One 2011; 6:e17027.
19. Garcia-Sureda L, Doménech-Sánchez A, Barbier M, Juan C, Gascó J, Albertí S. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother 2011; 55:4742-7.
20. Abdelraouf K, Kabbara S, Ledesma KR, Poole K, Tam VH. Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa. J Antimicrob Chemother 2011; 66:1311-7.
21. Catel-Ferreira M, Nehmé R, Molle V, et al. Deciphering the function of the outer membrane protein OprD homologue of Acinetobacter baumannii. Antimicrob Agents Chemother 2012; 56:3826-32.
22. Fernandez-Cuenca F, Smani Y, Gómez-Sánchez MC, et al. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter bauman-nii is associated with decreased expression of genes encoding the porins CarO and OprD-like. Int J Antimicrob Agents Chemother 2011; 38:548-9.
23. Fernández-Reyes M, Rodríguez-Falcón M, Chiva C, Pachón J, Andreu DRivas L. The cost of resistance to colistin in Acinetobacter baumannii: A proteomic perspective. Proteomics 2009; 9:1632-45.
24. López-Rojas R, Domínguez-Herrera J, McConnell MJ, et al. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 2011; 203:545-8.
25. Garcia-Quintanilla M, Pulido MR, López-Rojas MR, Pachón J, McConnell MJ. Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol 2013; 21:157-63.